PreveCeutical Medical Inc.
PRVCF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$8.97M
Close$
$-0.01
146.1% downside
Current Fair Value
146.1% downsideOvervalued by 146.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $8.97 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | 0.07 |
| Outstanding Shares | 603,491,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -12.5 |
|---|---|
| PEG | 21.98 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About PreveCeutical Medical Inc.
5 employees
CEO: Stephen Van Deventer
PreveCeutical Medical Inc. is a health sciences firm dedicated to creating preventative and therapeutic solutions, employing compounds that are either organic or identical to natural substances. Its robust product pipeline features the C...